Filing Flows › Comparisons › GKOS vs OFIX
Glaukos vs Orthofix Medical: GKOS and OFIX compared
Glaukos is the larger company: $211M of revenue in its latest quarter (Q3 2026) against $211M for Orthofix Medical (Q2 FY26). Glaukos is growing faster (+58% against +4% a year earlier). Glaukos is more profitable, with an operating margin of 0.4% against -3.9%.
Where the money goes: GKOS and OFIX
Glaukos (GKOS) · Q3 2026
Glaukos, Q3 2026: revenue $211M (+58% year over year), operating margin 0.4%, net earnings $2.0M, operating cash flow $38.6M. The chart follows the revenue to costs, profit and cash.
Orthofix Medical (OFIX) · Q2 FY26
Orthofix Medical, Q2 FY26: revenue $211M (+4% year over year), operating margin -3.9%, net loss $15.8M, operating cash flow −$6.2M. The chart follows the revenue to costs, profit and cash.
| Glaukos (GKOS) | Orthofix Medical (OFIX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 FY26 |
| Revenue | $211M | $211M |
| Revenue growth, Y/Y | +58% | +4% |
| Gross margin | 85.2% | — |
| Operating margin | 0.4% | -3.9% |
| Net earnings | $2.0M | −$15.8M |
| Net margin | 1.0% | -7.5% |
| Operating cash flow | $38.6M | −$6.2M |
| Free cash flow | $36.5M | — |
| Market value | $11.1B | — |
| Analysts’ mean target | $242.46 | — |
Where the revenue comes from
Glaukos
- Glaucoma: $152M (72%)
- Corneal Health: $59.0M (28%)
Orthofix Medical
- Global Spine: $173M (82%)
- Global Limb Reconstruction: $37.7M (18%)
Questions
Which is bigger, Glaukos or Orthofix Medical?
Glaukos is the larger company: $211M of revenue in its latest quarter (Q3 2026) against $211M for Orthofix Medical (Q2 FY26).
Is Glaukos or Orthofix Medical growing faster?
Glaukos is growing faster (+58% against +4% a year earlier).
Which is more profitable, Glaukos or Orthofix Medical?
Glaukos is more profitable, with an operating margin of 0.4% against -3.9%.
More: Glaukos earnings · how Glaukos makes money · Orthofix Medical earnings · how Orthofix Medical makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 28, 2026; 10-Q filed Aug 5, 2026). Fiscal quarters can end on different dates. Not investment advice.